Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxa2
|
ENSMUSG00000014704.8 | homeobox A2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_52161787_52162301 | Hoxa2 | 2787 | 0.079534 | 0.46 | 2.1e-04 | Click! |
chr6_52164011_52165366 | Hoxa2 | 143 | 0.825507 | 0.45 | 2.9e-04 | Click! |
chr6_52162888_52164000 | Hoxa2 | 1387 | 0.150666 | 0.45 | 3.0e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_32001099_32002296 | 8.52 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr18_25750468_25751272 | 7.65 |
Celf4 |
CUGBP, Elav-like family member 4 |
1822 |
0.41 |
chr2_65620767_65621991 | 7.39 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr12_29534253_29535510 | 7.30 |
Gm20208 |
predicted gene, 20208 |
10 |
0.8 |
chr13_109442519_109443753 | 6.40 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
953 |
0.73 |
chr2_74734325_74737080 | 6.34 |
Hoxd3 |
homeobox D3 |
813 |
0.31 |
chr13_109927479_109928182 | 6.33 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
986 |
0.65 |
chr15_91017138_91018295 | 6.11 |
Kif21a |
kinesin family member 21A |
32102 |
0.16 |
chr13_8205494_8206737 | 6.07 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
3193 |
0.23 |
chr14_66865047_66865736 | 5.94 |
Dpysl2 |
dihydropyrimidinase-like 2 |
3297 |
0.19 |
chr12_72233267_72233815 | 5.94 |
Rtn1 |
reticulon 1 |
2198 |
0.35 |
chr19_44758783_44762005 | 5.94 |
Pax2 |
paired box 2 |
479 |
0.75 |
chr9_110051810_110053856 | 5.63 |
Map4 |
microtubule-associated protein 4 |
781 |
0.54 |
chr17_90452047_90452824 | 5.50 |
Nrxn1 |
neurexin I |
2387 |
0.31 |
chr11_96329848_96331152 | 5.47 |
Hoxb3 |
homeobox B3 |
2438 |
0.11 |
chr5_150261018_150262108 | 5.39 |
Fry |
FRY microtubule binding protein |
1796 |
0.34 |
chr7_99272446_99273539 | 5.39 |
Map6 |
microtubule-associated protein 6 |
3860 |
0.15 |
chr12_80759551_80760722 | 5.12 |
Ccdc177 |
coiled-coil domain containing 177 |
551 |
0.62 |
chr10_90577565_90578158 | 5.11 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
869 |
0.72 |
chr2_158375202_158376961 | 5.09 |
Snhg11 |
small nucleolar RNA host gene 11 |
319 |
0.74 |
chr11_69211021_69211683 | 5.08 |
Alox8 |
arachidonate 8-lipoxygenase |
13509 |
0.1 |
chr9_110053895_110054422 | 5.05 |
Map4 |
microtubule-associated protein 4 |
2106 |
0.22 |
chr19_32102301_32103300 | 5.03 |
Asah2 |
N-acylsphingosine amidohydrolase 2 |
324 |
0.92 |
chr2_24473566_24475385 | 5.00 |
Pax8 |
paired box 8 |
622 |
0.64 |
chr7_60939270_60939914 | 4.98 |
Gm44644 |
predicted gene 44644 |
16682 |
0.22 |
chr11_77930982_77932135 | 4.98 |
Sez6 |
seizure related gene 6 |
519 |
0.68 |
chr18_25751839_25752425 | 4.96 |
Celf4 |
CUGBP, Elav-like family member 4 |
560 |
0.81 |
chr12_29529828_29531185 | 4.95 |
Gm20208 |
predicted gene, 20208 |
609 |
0.74 |
chr2_37517668_37518398 | 4.95 |
Gpr21 |
G protein-coupled receptor 21 |
1407 |
0.29 |
chr12_72234504_72235243 | 4.95 |
Rtn1 |
reticulon 1 |
866 |
0.66 |
chr16_81203792_81204456 | 4.91 |
Ncam2 |
neural cell adhesion molecule 2 |
3367 |
0.33 |
chr10_92163758_92164191 | 4.84 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
692 |
0.72 |
chr11_55604950_55605292 | 4.76 |
Glra1 |
glycine receptor, alpha 1 subunit |
2612 |
0.3 |
chr5_120424691_120425521 | 4.69 |
Lhx5 |
LIM homeobox protein 5 |
6593 |
0.14 |
chr2_164967685_164969910 | 4.69 |
Slc12a5 |
solute carrier family 12, member 5 |
516 |
0.7 |
chr9_43069907_43070263 | 4.60 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
27453 |
0.17 |
chr3_17792584_17792950 | 4.50 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1153 |
0.46 |
chr9_75610075_75610368 | 4.45 |
Tmod2 |
tropomodulin 2 |
854 |
0.52 |
chr4_49842278_49843034 | 4.43 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
2893 |
0.36 |
chrX_130502898_130503405 | 4.42 |
Gm14987 |
predicted gene 14987 |
10638 |
0.22 |
chr15_85680534_85681451 | 4.42 |
Lncppara |
long noncoding RNA near Ppara |
22781 |
0.12 |
chr10_57784547_57786586 | 4.40 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr1_157243489_157244692 | 4.40 |
Rasal2 |
RAS protein activator like 2 |
400 |
0.88 |
chr15_98949772_98950556 | 4.39 |
Gm49450 |
predicted gene, 49450 |
3387 |
0.1 |
chr1_9601164_9602408 | 4.37 |
Vxn |
vexin |
587 |
0.67 |
chr11_55606213_55606456 | 4.36 |
Glra1 |
glycine receptor, alpha 1 subunit |
1399 |
0.46 |
chr14_64574784_64575443 | 4.35 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
12218 |
0.15 |
chr2_34368351_34369364 | 4.31 |
Pbx3 |
pre B cell leukemia homeobox 3 |
1989 |
0.33 |
chr15_61690376_61690923 | 4.26 |
D030024E09Rik |
RIKEN cDNA D030024E09 gene |
54535 |
0.16 |
chr11_96328778_96329079 | 4.22 |
Hoxb3 |
homeobox B3 |
866 |
0.33 |
chr17_91091821_91092017 | 4.21 |
Nrxn1 |
neurexin I |
814 |
0.55 |
chr10_92162169_92163486 | 4.21 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
66 |
0.98 |
chr8_90345047_90345661 | 4.20 |
Tox3 |
TOX high mobility group box family member 3 |
2772 |
0.42 |
chr18_35210523_35210985 | 4.18 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
4176 |
0.2 |
chr11_55681118_55681696 | 4.17 |
Glra1 |
glycine receptor, alpha 1 subunit |
73209 |
0.1 |
chr6_52173541_52173983 | 4.16 |
Gm15050 |
predicted gene 15050 |
881 |
0.24 |
chr6_121472423_121472626 | 4.13 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
1099 |
0.53 |
chr8_109245493_109246323 | 4.12 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr6_83171941_83172736 | 4.12 |
Gm15624 |
predicted gene 15624 |
216 |
0.83 |
chr4_125493147_125493641 | 4.07 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
2694 |
0.27 |
chr10_116470404_116471142 | 4.01 |
Kcnmb4os2 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4, opposite strand 2 |
2390 |
0.2 |
chr7_36710059_36710756 | 4.00 |
Gm37452 |
predicted gene, 37452 |
233 |
0.9 |
chr11_104234777_104235157 | 3.98 |
Mapt |
microtubule-associated protein tau |
3383 |
0.19 |
chr5_32153164_32153923 | 3.98 |
Fosl2 |
fos-like antigen 2 |
7022 |
0.15 |
chr16_77596529_77597235 | 3.97 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1980 |
0.16 |
chr16_77537075_77537402 | 3.97 |
Gm36963 |
predicted gene, 36963 |
2644 |
0.18 |
chr11_66524173_66524698 | 3.96 |
Shisa6 |
shisa family member 6 |
1360 |
0.55 |
chr2_13129465_13129716 | 3.96 |
Gm38156 |
predicted gene, 38156 |
11155 |
0.19 |
chr10_110454837_110455019 | 3.91 |
Nav3 |
neuron navigator 3 |
1276 |
0.51 |
chr2_6883618_6884699 | 3.86 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr9_41585694_41587243 | 3.86 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chr14_65423052_65425451 | 3.79 |
Pnoc |
prepronociceptin |
909 |
0.6 |
chr1_50929921_50930145 | 3.76 |
Tmeff2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
2514 |
0.33 |
chr7_60000800_60001315 | 3.76 |
Snurf |
SNRPN upstream reading frame |
3992 |
0.08 |
chr8_54958887_54959474 | 3.75 |
Gm45263 |
predicted gene 45263 |
639 |
0.67 |
chr12_52699823_52700029 | 3.72 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
543 |
0.8 |
chr2_181715341_181715994 | 3.72 |
Oprl1 |
opioid receptor-like 1 |
35 |
0.95 |
chrX_88113433_88114223 | 3.71 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
1817 |
0.46 |
chr6_39875361_39875680 | 3.69 |
Tmem178b |
transmembrane protein 178B |
2449 |
0.23 |
chr7_140821200_140821421 | 3.69 |
Zfp941 |
zinc finger protein 941 |
822 |
0.35 |
chrX_152643367_152644550 | 3.67 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr2_116056837_116059755 | 3.67 |
Meis2 |
Meis homeobox 2 |
546 |
0.75 |
chr13_99513069_99513554 | 3.66 |
Map1b |
microtubule-associated protein 1B |
3207 |
0.2 |
chr8_45509543_45510137 | 3.65 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
1922 |
0.33 |
chr1_66321652_66322390 | 3.65 |
Map2 |
microtubule-associated protein 2 |
23 |
0.98 |
chr19_45230983_45235468 | 3.65 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr10_92164315_92164805 | 3.63 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
106 |
0.97 |
chr9_51766580_51766745 | 3.63 |
Arhgap20 |
Rho GTPase activating protein 20 |
1002 |
0.63 |
chr13_44842998_44843173 | 3.62 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
2302 |
0.32 |
chr12_87026152_87027307 | 3.62 |
Tmem63c |
transmembrane protein 63c |
113 |
0.95 |
chr12_46816152_46816702 | 3.60 |
Nova1 |
NOVA alternative splicing regulator 1 |
533 |
0.8 |
chr2_124092543_124092695 | 3.59 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
2650 |
0.37 |
chr18_80979961_80981696 | 3.58 |
Sall3 |
spalt like transcription factor 3 |
5708 |
0.14 |
chr6_52164011_52165366 | 3.58 |
Hoxa2 |
homeobox A2 |
143 |
0.83 |
chrX_103184741_103184892 | 3.56 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
1824 |
0.25 |
chr3_102010824_102010979 | 3.56 |
Nhlh2 |
nescient helix loop helix 2 |
746 |
0.67 |
chr14_66347306_66348516 | 3.55 |
Stmn4 |
stathmin-like 4 |
3530 |
0.22 |
chr12_31712818_31713098 | 3.55 |
Gpr22 |
G protein-coupled receptor 22 |
968 |
0.51 |
chr5_74676974_74677904 | 3.54 |
Lnx1 |
ligand of numb-protein X 1 |
190 |
0.94 |
chr4_110289784_110290066 | 3.53 |
Elavl4 |
ELAV like RNA binding protein 4 |
347 |
0.93 |
chr5_69338848_69339239 | 3.53 |
Gm24368 |
predicted gene, 24368 |
1740 |
0.27 |
chr7_79501250_79502506 | 3.53 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr1_166948030_166948507 | 3.51 |
Gm6286 |
predicted gene 6286 |
1910 |
0.38 |
chr9_43070574_43070912 | 3.51 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
28111 |
0.16 |
chr1_178531534_178532270 | 3.50 |
Kif26b |
kinesin family member 26B |
2777 |
0.33 |
chr8_114770688_114771203 | 3.49 |
Wwox |
WW domain-containing oxidoreductase |
58778 |
0.14 |
chr3_84217847_84218683 | 3.48 |
Trim2 |
tripartite motif-containing 2 |
2580 |
0.33 |
chr11_76466993_76468433 | 3.46 |
Abr |
active BCR-related gene |
585 |
0.77 |
chr6_103513736_103514218 | 3.45 |
Chl1 |
cell adhesion molecule L1-like |
2647 |
0.25 |
chr13_48266007_48266319 | 3.45 |
A330033J07Rik |
RIKEN cDNA A330033J07 gene |
3540 |
0.15 |
chr4_140244024_140245271 | 3.44 |
Igsf21 |
immunoglobulin superfamily, member 21 |
2137 |
0.36 |
chr4_13755753_13756054 | 3.44 |
Runx1t1 |
RUNX1 translocation partner 1 |
4606 |
0.33 |
chr12_41483283_41485192 | 3.44 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr1_3667888_3668100 | 3.41 |
Xkr4 |
X-linked Kx blood group related 4 |
3504 |
0.21 |
chr10_101681584_101682324 | 3.40 |
Mgat4c |
MGAT4 family, member C |
208 |
0.96 |
chr2_158610228_158611991 | 3.39 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
342 |
0.44 |
chr5_114090407_114091746 | 3.39 |
Svop |
SV2 related protein |
291 |
0.84 |
chr10_18470218_18471289 | 3.38 |
Nhsl1 |
NHS-like 1 |
772 |
0.72 |
chr16_75090895_75091748 | 3.37 |
Gm49676 |
predicted gene, 49676 |
55912 |
0.14 |
chr6_13835523_13837039 | 3.37 |
Gpr85 |
G protein-coupled receptor 85 |
960 |
0.59 |
chr13_44843445_44844028 | 3.36 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
2953 |
0.28 |
chr1_61472065_61473256 | 3.36 |
Gm25839 |
predicted gene, 25839 |
2219 |
0.24 |
chr1_81079064_81079824 | 3.36 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
1861 |
0.49 |
chr10_109830543_109831446 | 3.36 |
Nav3 |
neuron navigator 3 |
2227 |
0.45 |
chr3_8513445_8513907 | 3.35 |
Stmn2 |
stathmin-like 2 |
4090 |
0.25 |
chr2_74732545_74733279 | 3.34 |
Hoxd3 |
homeobox D3 |
1 |
0.92 |
chr2_116053626_116054503 | 3.33 |
Meis2 |
Meis homeobox 2 |
4384 |
0.2 |
chr6_39874717_39875333 | 3.31 |
Tmem178b |
transmembrane protein 178B |
1954 |
0.27 |
chr16_77759702_77760329 | 3.30 |
Gm37694 |
predicted gene, 37694 |
74738 |
0.07 |
chr8_14382368_14383445 | 3.29 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr19_15516574_15517276 | 3.26 |
Gm24319 |
predicted gene, 24319 |
163079 |
0.04 |
chr1_66322405_66322814 | 3.24 |
Map2 |
microtubule-associated protein 2 |
507 |
0.79 |
chr3_76075976_76076354 | 3.23 |
Fstl5 |
follistatin-like 5 |
582 |
0.8 |
chr11_105731735_105732401 | 3.20 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
18528 |
0.2 |
chr5_117415009_117415179 | 3.19 |
Ksr2 |
kinase suppressor of ras 2 |
1094 |
0.42 |
chr2_32430451_32431664 | 3.19 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
47 |
0.95 |
chr3_158559356_158560580 | 3.18 |
Lrrc7 |
leucine rich repeat containing 7 |
1368 |
0.57 |
chr9_43069102_43069597 | 3.18 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
26717 |
0.17 |
chr9_75683375_75684591 | 3.17 |
Scg3 |
secretogranin III |
8 |
0.97 |
chr15_44705107_44706053 | 3.14 |
Sybu |
syntabulin (syntaxin-interacting) |
42208 |
0.15 |
chr7_139833633_139836105 | 3.13 |
Adgra1 |
adhesion G protein-coupled receptor A1 |
93 |
0.96 |
chrX_48523279_48523924 | 3.12 |
Rab33a |
RAB33A, member RAS oncogene family |
4316 |
0.19 |
chr2_14740186_14740953 | 3.12 |
Gm10848 |
predicted gene 10848 |
847 |
0.36 |
chr5_115908055_115909691 | 3.11 |
Cit |
citron |
1403 |
0.37 |
chr10_18408068_18409081 | 3.09 |
Nhsl1 |
NHS-like 1 |
899 |
0.67 |
chr11_96334278_96335532 | 3.08 |
Hoxb3 |
homeobox B3 |
6040 |
0.08 |
chr5_16646262_16646815 | 3.08 |
Gm42975 |
predicted gene 42975 |
40816 |
0.16 |
chr13_8207058_8207829 | 3.08 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
4521 |
0.2 |
chr2_136054231_136054575 | 3.07 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
2164 |
0.34 |
chr19_23761309_23761998 | 3.07 |
Apba1 |
amyloid beta (A4) precursor protein binding, family A, member 1 |
2766 |
0.22 |
chr10_89256685_89257951 | 3.07 |
Ano4 |
anoctamin 4 |
18 |
0.99 |
chr5_37244380_37244680 | 3.07 |
Crmp1 |
collapsin response mediator protein 1 |
1234 |
0.48 |
chr2_181766837_181767244 | 3.06 |
Myt1 |
myelin transcription factor 1 |
2 |
0.97 |
chr5_66678440_66678918 | 3.05 |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
1787 |
0.24 |
chr15_92441686_92442277 | 3.05 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
44680 |
0.19 |
chr1_172056022_172057415 | 3.03 |
Nhlh1 |
nescient helix loop helix 1 |
855 |
0.45 |
chr12_61527782_61528209 | 3.02 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
4047 |
0.23 |
chr4_109343931_109344459 | 3.01 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
942 |
0.57 |
chr8_26438640_26439210 | 3.01 |
Gm45580 |
predicted gene 45580 |
96 |
0.96 |
chr2_113827975_113828215 | 3.01 |
Scg5 |
secretogranin V |
667 |
0.72 |
chr18_83192582_83193531 | 3.00 |
1700095A13Rik |
RIKEN cDNA 1700095A13 gene |
85166 |
0.08 |
chr1_20428374_20428954 | 2.99 |
Gm15795 |
predicted gene 15795 |
16146 |
0.17 |
chr3_114906056_114906421 | 2.99 |
Olfm3 |
olfactomedin 3 |
1603 |
0.51 |
chr9_121403057_121404479 | 2.98 |
Trak1 |
trafficking protein, kinesin binding 1 |
290 |
0.91 |
chr2_152081612_152083149 | 2.97 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr12_46817370_46817521 | 2.97 |
Nova1 |
NOVA alternative splicing regulator 1 |
485 |
0.82 |
chr7_24483306_24483457 | 2.96 |
Cadm4 |
cell adhesion molecule 4 |
1358 |
0.23 |
chr16_85169623_85170249 | 2.96 |
Gm27295 |
predicted gene, 27295 |
1087 |
0.49 |
chr17_47143536_47144571 | 2.96 |
Trerf1 |
transcriptional regulating factor 1 |
2837 |
0.31 |
chr11_19350682_19351452 | 2.96 |
Gm12025 |
predicted gene 12025 |
10002 |
0.25 |
chr4_110285468_110287125 | 2.95 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr18_35213481_35213842 | 2.95 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1269 |
0.34 |
chr18_80988863_80989916 | 2.95 |
Gm27239 |
predicted gene 27239 |
1933 |
0.23 |
chrX_152642489_152643012 | 2.93 |
Shroom2 |
shroom family member 2 |
1174 |
0.54 |
chr8_99413145_99413446 | 2.93 |
Cdh8 |
cadherin 8 |
3024 |
0.28 |
chr17_70521708_70522843 | 2.93 |
Dlgap1 |
DLG associated protein 1 |
113 |
0.98 |
chr8_12947702_12949640 | 2.92 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr3_80798105_80798468 | 2.92 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
4293 |
0.29 |
chr6_93911862_93913573 | 2.90 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr4_90437640_90438299 | 2.90 |
Gm12635 |
predicted gene 12635 |
14905 |
0.24 |
chrX_143518219_143519318 | 2.90 |
Pak3 |
p21 (RAC1) activated kinase 3 |
70 |
0.98 |
chr15_98950561_98950712 | 2.89 |
Gm49450 |
predicted gene, 49450 |
2915 |
0.1 |
chr5_38151138_38153189 | 2.89 |
Nsg1 |
neuron specific gene family member 1 |
6868 |
0.16 |
chr14_124675118_124677112 | 2.89 |
Fgf14 |
fibroblast growth factor 14 |
1012 |
0.63 |
chr13_78194258_78194409 | 2.89 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
2040 |
0.23 |
chr6_28828230_28829085 | 2.88 |
Lrrc4 |
leucine rich repeat containing 4 |
1688 |
0.37 |
chr5_122048053_122048751 | 2.87 |
Gm15637 |
predicted gene 15637 |
20 |
0.9 |
chrX_49272929_49273965 | 2.86 |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
14765 |
0.24 |
chr8_48508743_48509680 | 2.86 |
Tenm3 |
teneurin transmembrane protein 3 |
46102 |
0.19 |
chr7_48964377_48965190 | 2.85 |
Nav2 |
neuron navigator 2 |
5686 |
0.18 |
chr12_53180085_53180359 | 2.85 |
Npas3 |
neuronal PAS domain protein 3 |
67935 |
0.13 |
chr1_143643975_143644626 | 2.85 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
1775 |
0.33 |
chr8_93814307_93815014 | 2.85 |
4930488L21Rik |
RIKEN cDNA 4930488L21 gene |
938 |
0.54 |
chr11_96323074_96323798 | 2.84 |
Hoxb3 |
homeobox B3 |
110 |
0.9 |
chr2_28211869_28212040 | 2.84 |
Olfm1 |
olfactomedin 1 |
6295 |
0.25 |
chr15_25411393_25411893 | 2.83 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
2055 |
0.24 |
chr4_36949218_36949456 | 2.82 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
1130 |
0.55 |
chr1_109986155_109986359 | 2.82 |
Cdh7 |
cadherin 7, type 2 |
2520 |
0.44 |
chr2_85197983_85199004 | 2.82 |
Lrrc55 |
leucine rich repeat containing 55 |
1296 |
0.28 |
chr2_70126636_70126952 | 2.81 |
Myo3b |
myosin IIIB |
30496 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 19.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
4.3 | 12.9 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
4.2 | 16.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
3.2 | 9.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.5 | 2.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
2.3 | 6.8 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
1.9 | 5.6 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.7 | 5.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.6 | 8.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.6 | 4.7 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.5 | 4.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.4 | 4.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.3 | 4.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.3 | 2.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.3 | 9.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.2 | 11.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
1.2 | 3.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.1 | 3.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.1 | 2.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.1 | 4.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
1.1 | 13.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.0 | 1.0 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.0 | 3.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.0 | 5.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.9 | 0.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.9 | 3.8 | GO:0007412 | axon target recognition(GO:0007412) |
0.9 | 2.8 | GO:0048880 | sensory system development(GO:0048880) |
0.9 | 7.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.9 | 2.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.8 | 3.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.8 | 3.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.8 | 2.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.8 | 1.5 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.7 | 2.2 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.7 | 3.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.7 | 1.4 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.7 | 5.8 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.7 | 5.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.7 | 4.8 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.7 | 2.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.7 | 11.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.7 | 5.9 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 4.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.6 | 1.9 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.6 | 4.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.6 | 1.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 3.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.6 | 1.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.6 | 1.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 1.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 4.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.6 | 1.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 2.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.6 | 2.4 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.6 | 3.0 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.6 | 14.9 | GO:0001964 | startle response(GO:0001964) |
0.6 | 1.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 1.8 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.6 | 4.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.6 | 1.1 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 1.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.5 | 0.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.5 | 1.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.5 | 1.6 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.5 | 4.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 1.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.5 | 5.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 2.6 | GO:0070842 | aggresome assembly(GO:0070842) |
0.5 | 8.9 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 1.5 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.5 | 0.5 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.5 | 3.9 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.5 | 1.9 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 3.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 1.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 1.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 0.5 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.5 | 1.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 0.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 0.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 0.9 | GO:0021546 | rhombomere development(GO:0021546) |
0.4 | 2.2 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 0.4 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.4 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.3 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 0.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.4 | 3.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 1.2 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.4 | 2.5 | GO:0048840 | otolith development(GO:0048840) |
0.4 | 1.2 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.4 | 4.5 | GO:0035640 | exploration behavior(GO:0035640) |
0.4 | 0.8 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.4 | 8.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.4 | 1.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 1.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 1.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.4 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 0.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.4 | 1.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.4 | 0.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.4 | 0.7 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.4 | 1.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 1.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 1.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 1.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 1.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.4 | 2.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 1.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.4 | 2.5 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.4 | 0.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.4 | 2.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 4.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.4 | 2.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 2.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 1.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 1.7 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.3 | 1.0 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.3 | 1.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 15.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 1.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 4.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 0.9 | GO:0030070 | insulin processing(GO:0030070) |
0.3 | 1.9 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.3 | 0.6 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 0.6 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.3 | 0.3 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.3 | 0.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 1.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 1.8 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 1.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 0.3 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.3 | 1.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 1.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 1.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.3 | 9.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 1.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 | 2.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 1.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 1.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 0.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 1.2 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
0.3 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
0.3 | 2.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 0.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 0.3 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.3 | 0.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.3 | 1.1 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 0.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.3 | 1.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.8 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 19.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 2.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.3 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.3 | 1.8 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.3 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 8.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 0.5 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.3 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.8 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 0.8 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 2.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 5.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 1.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 1.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 1.0 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 1.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.2 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.2 | 7.7 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 1.7 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 1.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 2.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.2 | 0.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 2.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 4.8 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 1.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 1.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 5.4 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.2 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.2 | 0.5 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 0.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 3.4 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.2 | 1.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.4 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.2 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 1.8 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 1.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.4 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 0.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 4.2 | GO:0032094 | response to food(GO:0032094) |
0.2 | 1.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 3.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 0.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.4 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.2 | 1.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.2 | 0.4 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.9 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.4 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.2 | 0.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.2 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.4 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 0.7 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 1.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 2.2 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.3 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.2 | 1.0 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.2 | 1.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.3 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.2 | 1.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.7 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 0.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 1.5 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.2 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.2 | 4.4 | GO:0008542 | visual learning(GO:0008542) |
0.2 | 0.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 1.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.2 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.2 | 0.3 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 0.3 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.2 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.7 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.1 | 1.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 1.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.4 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.9 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.1 | 0.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 2.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.4 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 1.3 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.1 | 7.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.5 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 2.3 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.5 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 1.1 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.1 | 0.4 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 1.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 2.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.3 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.1 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.1 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.5 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.4 | GO:0003140 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
0.1 | 0.5 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.1 | 0.4 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 1.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.1 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.1 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.2 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 0.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 1.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 1.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 3.6 | GO:0007612 | learning(GO:0007612) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 1.1 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.3 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 1.6 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 7.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 3.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.7 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 2.0 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.7 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 1.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.2 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.1 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.8 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.1 | 0.6 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.1 | 0.2 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.4 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 2.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 1.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 1.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 1.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.3 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0072506 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
0.1 | 0.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.3 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.5 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 1.1 | GO:0032402 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.1 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.3 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.1 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 1.7 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 1.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.2 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.1 | 0.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.7 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.4 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.1 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.5 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.2 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.2 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.4 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.7 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.1 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 1.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 1.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.3 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.5 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.1 | 2.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.7 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.2 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.1 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 1.6 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 2.4 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.3 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.1 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 4.1 | GO:0007409 | axonogenesis(GO:0007409) |
0.0 | 0.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.0 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.0 | 0.1 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) |
0.0 | 0.0 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.7 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.0 | 0.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.2 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.0 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.6 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.0 | 0.2 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.0 | 0.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 1.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 2.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.2 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.0 | 0.3 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 2.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.0 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.0 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.0 | 0.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.8 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.0 | 0.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.3 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 1.4 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.2 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0086019 | cell-cell signaling involved in cardiac conduction(GO:0086019) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 0.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.1 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.0 | 0.0 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.0 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.0 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.0 | GO:0070305 | response to cGMP(GO:0070305) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.0 | 0.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.0 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.0 | 0.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.0 | 0.2 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.2 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.0 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.0 | 0.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.0 | 0.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.1 | GO:1904063 | negative regulation of cation transmembrane transport(GO:1904063) |
0.0 | 0.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.0 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.0 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.1 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.2 | 3.7 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 19.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.9 | 6.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.9 | 6.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 6.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 7.6 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 3.0 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 22.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 36.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 1.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 5.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 3.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 3.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 2.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.5 | 1.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.5 | 13.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 1.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 0.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 18.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 4.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 4.3 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 4.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 3.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 50.1 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 9.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 0.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.3 | 0.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 3.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 6.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 3.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 1.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 1.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 1.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 6.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 1.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 1.3 | GO:0097433 | dense body(GO:0097433) |
0.3 | 0.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 3.1 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 12.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 6.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 1.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.3 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 10.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 0.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 0.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 3.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 13.3 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 1.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 18.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.7 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 2.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 1.1 | GO:0043205 | fibril(GO:0043205) |
0.1 | 5.9 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 1.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 5.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.1 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.6 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 3.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.6 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 6.9 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 7.8 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.4 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 3.8 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.0 | 4.2 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 1.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 1.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.0 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.1 | 9.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.6 | 6.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.6 | 9.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.5 | 7.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.1 | 5.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.1 | 7.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.1 | 9.8 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.0 | 4.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.0 | 2.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.9 | 7.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.9 | 2.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.8 | 4.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.8 | 21.1 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.8 | 7.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.8 | 4.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 3.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.8 | 4.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 2.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 2.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 2.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.6 | 3.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.6 | 4.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.6 | 1.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.5 | 1.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 2.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 1.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 5.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.5 | 2.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 2.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 2.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 5.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 3.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 1.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 3.3 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 1.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 1.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 1.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 3.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 1.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 1.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 2.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 2.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 1.5 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 7.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 0.4 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.4 | 1.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.3 | 7.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 7.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 2.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 2.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 0.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 4.7 | GO:0031402 | sodium ion binding(GO:0031402) |
0.3 | 0.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 0.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 3.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 2.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 5.0 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 0.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 10.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 0.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 0.8 | GO:0047074 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.3 | 4.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 1.0 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.3 | 1.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 3.0 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 4.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 5.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.2 | 1.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 3.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 4.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 5.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 1.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 2.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 2.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 6.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 4.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 3.6 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.6 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 2.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 2.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 4.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 2.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.9 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 2.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 1.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.2 | 0.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 1.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 4.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 1.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 1.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 1.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 1.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 1.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 1.4 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 3.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 3.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 2.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 3.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 1.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 4.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 1.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 2.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 1.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 1.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 1.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 3.2 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 2.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 2.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 0.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 1.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 4.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 1.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.8 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 1.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.0 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 2.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 1.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 1.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 3.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 1.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.6 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 1.2 | GO:0018451 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 0.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 1.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 6.6 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.2 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 2.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.2 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.0 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 26.3 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 4.8 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.7 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 1.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 12.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 1.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.2 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.0 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 7.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 7.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 4.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 5.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 11.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.4 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 4.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 8.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 5.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 2.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 1.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 6.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 2.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 20.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 17.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.8 | 18.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 8.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 4.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 10.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 7.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 7.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 10.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 6.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 12.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 0.4 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.4 | 0.4 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.3 | 7.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 3.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 0.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 4.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 0.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 2.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 4.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 2.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 0.2 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.2 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 2.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 1.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 4.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 5.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 2.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 17.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 2.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.1 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 1.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 5.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.4 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 1.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.5 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |